Evidence map›Paper›PMID 32085857›Full record

ReviewSeminars in perinatology2020

A common clinical conundrum: Antidepressant treatment of depression in pregnant women.

Gabrielle A Mesches, Katherine L Wisner, Hannah K Betcher

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in perinatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. St. John's Wort usage in treating of perinatal depression.Frontiers in behavioral neuroscience · 2022
    Article
  9. Article
  10. Article
  11. Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gabrielle A MeschesDepartment of Psychiatry, Northwestern University Feinberg School of Medicine, 676 North St. Clair St. Suite 1000, Chicago, IL, United States.
Katherine L WisnerDepartment of Psychiatry, Northwestern University Feinberg School of Medicine, 676 North St. Clair St. Suite 1000, Chicago, IL, United States; Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Electronic address: Katherine.wisner@northwestern.edu.
Hannah K BetcherMayo Clinic, Rochester, MN, United States.
Northwestern University · USMayo Clinic in Arizona · US

Funding

Plasma SSRI Concentrations and CYP450 Activity Across ChildbearingU54HD085601 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEORGE, ALFRED L. · 2015 to 2019
$3.9M
NICHD NIH HHS U54 HD085601
6 · The paper itself

Abstract

Depression during pregnancy is associated with adverse maternal, pregnancy, and infant outcomes. Treatment during pregnancy requires a balanced discussion of the risks of both drug exposure and untreated depression. An updated review of the epidemiology, outcomes, and management of maternal depression is presented. Adverse outcomes are associated with both maternal depression and antidepressants. Research gaps include data on the longitudinal developmental trajectory of offspring exposed to antidepressants compared to depression, with assessment of in utero symptom exposure and environmental exposures. Additionally, neonatal syndrome associated with antidepressant use during pregnancy has no consensus definition or mechanistic explanation. With sophisticated large-scale epidemiologic studies, there has been progress in distinguishing the impact of depression processes from medication used for treatment. Optimal treatment of perinatal depression includes close symptom monitoring and medication adjustments to maintain symptom remission. This evolving field requires frequent consultation with reproductive data sources included in this article.

Indexed as

Abortion, SpontaneousAntidepressive AgentsCongenital AbnormalitiesDepressive DisorderFemaleFetal Growth RetardationHumansInfant, NewbornMajor Depressive DisorderNeurodevelopmental DisordersPatient Health QuestionnairePregnancyPregnancy ComplicationsPremature BirthPrenatal Exposure Delayed EffectsRisk AssessmentAntidepressive Agentsantidepressantdepressionperinatalpsychopharmacologywomen's health

Identifiers

PMID32085857
PMCPMC7214132
OpenAlexW3002786719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.